Madison group hopes to raise profile of pancreatic cancer Wisconsin State Journal, WI - Nov 10, 2008 She specializes in gastrointestinal cancers including pancreatic cancer. Other hurdles: There is no routine screening test for pancreatic cancer, ...
US drug firm to open research unit in Qatar Peninsula On-line, Qatar - Nov 18, 2008 The screening tests will cover high risk prostrate, bladder and lung cancer patients. The surveillance tests will cover individuals susceptible to liver ...
New, Noted, Now: Now in Health Forbes, NY - Nov 14, 2008 --Ross Bonander You may know about vitamin D's role in preventing osteoporosis, diabetes, and cancers of the breast, ovaries, and bladder. ...
Happy Birthday, Love Canal Chemical & Engineering News - Nov 13, 2008 The draft also reported elevated rates of kidney, bladder, and lung cancers at Love Canal, though few of the comparisons were statistically significant. ...EPA:AN
Is this normal ovulation? Or it is a sign of cervical cancer? Daily Monitor, Uganda - Every woman who is sexually active or more than 18 years should carry out a PAP smear as a routine test to rule out the cancer which if caught early will be ...
Former Ticats head coach Ron Lancaster is battling lung cancer The Canadian Press, HAMILTON - In 2004, Lancaster battled bladder cancer. Lancaster began his illustrious CFL career in 1960 with the Ottawa Rough Riders. He was dealt to Saskatchewan in ...
Cancer: World`s worst killer Triumph, Nigeria - According to her, prostate cancer can usually be found in its early stages by having a Prostate-Specific Antigen (PSA) blood test and a Digital Rectal ...
Identifying Cancer Cells Allows Tumor-Specific Treatment HealthNews, CA - Aug 4, 2008 The assumption is usually that the location of the cancer cells is a good identification tool, such as bladder, colon and breast cancer. ...
MDs urged to quit prostate screens in elderly men The Associated Press - Aug 4, 2008 However, treatment often causes "moderate-to-substantial harms," including erectile dysfunction and bladder control and bowel problems. ...
The Unholy Trinity CounterPunch, CA - He is an educational software developer and bladder cancer survivor, as well as a collector of military and nuclear historical documents and books. ...
Improved Detection of Recurrent Bladder Cancer Using the Bard BTA stat Test. - MF Sarosdy, MA Hudson, WJ Ellis, MS Soloway, R … - The Journal of Urology, 1998 - jurology.com ... HUMAN COMPLEMENT FACTOR H RELATED PROTEIN TEST FOR MONITORING BLADDERCANCER. ... HUMAN
COMPLEMENT FACTOR H RELATED PROTEIN TEST FOR MONITORING BLADDERCANCER. ...
NMP22 IS A SENSITIVE, COST-EFFECTIVE TEST IN PATIENTS AT RISK FOR BLADDER CANCER - C ZIPPE, L PANDRANGI, A AGARWAL - The Journal of Urology, 1999 - Elsevier ... 36 with gross and 94 with microscopic hematuria, and 137 with frequency voiding
symptoms) at risk for bladdercancer with a negative NMP22 test (less than 10.0 ...
COMPARISON OF SCREENING METHODS IN THE DETECTION OF BLADDER CANCER. - S RAMAKUMAR, J BHUIYAN, JA BESSE, SG ROBERTS, PC … - The Journal of Urology, 1999 - jurology.com ... The Accu-Dx Recurrent BladderCancerTest* is a 1-step gold dye particle
immunoassay on a porous carrier (package insert). Urine ...
NONINVASIVE DETECTION OF BLADDER CANCER WITH THE BTA STAT TEST. - DOV PODE, A SHAPIRO, M WALD, O NATIV, M LAUFER, I … - The Journal of Urology, 1999 - jurology.com ... Conclusions: The BTA stat test can be used as a screening test for bladdercancer
in patients with hematuria or irritative voiding symptoms and for ...
Urine Detection of Survivin and Diagnosis of Bladder Cancer - SD Smith, MA Wheeler, J Plescia, JW Colberg, RM … - JAMA, 2001 - Am Med Assoc ... Three patients in group 5 with initial diagnosis of grade II noninvasive bladder cancer had positive test results for urine survivin after undergoing negative ...
Urine test helps detect 99 percent of recurring bladder cancers
A simple urine test that can be interpreted in a doctor's office can help detect nearly all recurrences of bladder cancers with a higher accuracy rate than conventional laboratory analysis of urine tests.
The BladderChek test, used in conjunction with a diagnostic scope, detected 99 percent of recurring bladder cancers.
The BladderChek test, which requires four drops of urine, detects elevated levels of the nuclear matrix protein NMP22, an indication of cancer even at early stages of the disease. A doctor or nurse can read the results in 30 to 50 minutes.
"You know the answer before the patient is out of your office," Barry Stein, at Brown Medical School says. " If the result is positive, and you didn't see anything from the cystoscopy, you would check to see if you missed something."
No single procedure is completely effective in detecting recurring bladder cancer, so physicians use a combination of methods – typically cystoscopy and a urine cytology test.
Cystoscopy, a minimally invasive procedure performed in a physician's office, enables physicians to view the wall of the bladder through a scope.
However, it may not detect very small tumors or tumors in the muscle or upper tract.
So in conjunction with the scope, physicians rely on cytology, a clinical analysis of a urine sample. The process can take a week or more, and requires expert interpretation. The analysis identifies changes in intact cells, but its sensitivity is dependent on the size and shape of the tumor.
In this study, 668 patients with a history of bladder cancer provided a urine sample before undergoing cystoscopy during follow-up visits with their physician.
The urine sample was analyzed with urine cytology, and with the BladderChek test.
Bladder cancer was identified in 103 patients.
Cytoscopy alone detected 94 cancers, and the BladderChek test detected 8 of 9 cancers that were not seen through the scope – 7 of them life-threatening.
The urine cytology only detected 3 of the 9 cancers.
Cystoscopy alone detected 91.3 percent of cancers. When cystoscopy was used with conventional urine analysis, the detection rate was 94.2 percent; when it was used with the BladderChek test, detection was 99 percent.
An accurate urine test could reduce the number of cystoscopies a patient undergoes, Stein says. While not painful, the procedure can be uncomfortable. By contrast, the BladderChek test is similar to a pregnancy test and gives objective results – if cancer is detected, a purple line appears.
The study has demonstrated that one day a simple urine test might replace cystoscopies.